Development of a blood proteins-based model for bronchopulmonary dysplasia prediction in premature infants

Wanting Ou1, KeJing Lei1, Huanhuan Wang1

  • 1Department of Pediatrics, Dazhou Central Hospital, Dazhou, Sichuan, China.

BMC Pediatrics
|June 17, 2023
PubMed

Insights

This study identifies key blood proteins that can predict bronchopulmonary dysplasia (BPD) in premature infants. This protein-based model offers a promising tool for early BPD detection and potential therapeutic targets.

Area of Science:

  • Neonatal Medicine
  • Pulmonary Medicine
  • Biomarker Discovery

Background:

  • Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in premature infants.
  • Early identification of BPD risk factors is crucial for timely intervention.
  • Blood proteins are potential early indicators for BPD development.

Purpose of the Study:

  • To develop a predictive model for BPD using blood protein expression profiles.
  • To identify specific proteins associated with BPD development in premature infants.
  • To explore potential therapeutic targets for BPD.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) data (GSE121097) including protein expression and clinical data.
  • Applied Weighted Gene Co-expression Network Analysis (WGCNA) and differential protein analysis.
  • Developed a BPD prediction model using Least Absolute Shrinkage and Selection Operator (LASSO) regression.

Main Results:

  • Identified significant protein modules (black, magenta, turquoise) correlated with BPD.
  • Found 59 overlapping proteins enriched in 253 Gene Ontology (GO) terms and 11 KEGG pathways.
  • LASSO analysis reduced these to 8 proteins, achieving high predictive performance (AUC 1.00 training, 0.96 testing).

Conclusions:

  • Established a reliable blood-protein based model for early BPD prediction in premature infants.
  • The identified proteins may offer insights into BPD pathogenesis.
  • This model could aid in reducing the burden and severity of BPD.
Abstract